Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ABVX Abivax SA | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $106.66 -6.1% | $16.00 -2.5% |
| StockIQ Score | 42D Weak Risk: Medium | 35F Weak Risk: High |
| Technical | 23F | 13F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 86A | 50C- |
| Quality | — | 50C- |
| Risk | 50C- | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Abivax (ABVX) and Ascentage Pharma (AAPG) both have "WEAK" ratings, but AAPG outperforms in measurable scores. AAPG’s technical score (18) is higher than ABVX’s (14), and it has strong growth (50) and valuation (38) scores, while ABVX lacks those details. AAPG shows clearer strength in available metrics.